separate channel within the cannula, which is connected to an integrated suction unit. The application cannulae vary in diameter, arrangement, and sharpness of openings. The flow rate of the infiltrate, as well as the application of variable intensities of negative pressure, can be selected at different levels, depending on the purpose. A sterile container can be connected between the working cannula and the suction pump to collect the aspirate under reduced negative pressures. The fat is separated from the infranate for immediate usage without centrifugation.
WAL relies on two tumescent subcutaneous infiltration solutions. A higher concentration of lidocaine in the infiltration solution is employed during Phase 1 to provide longer-lasting local anesthesia and vasoconstriction. A solution with lower lidocaine concentration is instilled during Phase 2 (simultaneous infiltration and aspiration) and Phase 3 (drying or finishing) to reduce the pharmacological effects of lidocaine and the accompanying fluid load.
Progressive improvements in the application of tumescent solutions, methodologies and instruments, and criteria for patient selection remain critical for patient safety and efficacy with any type of liposuction procedure. This preliminary report investigates whether saline rinsing of fatty tissue results in safe fluid and lidocaine management, minimal blood loss, consistent lipo shaping with tissue accommodation, efficient fat harvesting, transfer and survival, and low complication rates with acceptable outcomes.
Methods
WAL treatments are indicated for patients with moderate collections of adiposity and mild to moderate degrees of skin laxity, as well as for those who desire augmentation with their fat. Patient exclusion criteria for this study included pregnancy, uncontrolled diabetes mellitus, collagen disorders, cardiovascular diseases, and bleeding disorders. A total of 41 consecutive patients who presented to the author's private practice for body contouring were included in the study and treated with WAL-specifically, Body-Jet (Human Med, Eclipse Ltd., Dallas, Texas).
Standardized digital photography was obtained before surgery, along with data about each patient's weight, height, percentage body fat, and body mass index. Patients were marked in the standing and sitting positions (to localize zones of treatment), and the markings were confirmed by caliper measurements. Patients were offered preoperative oral medication for pain and sedation. An intravenous catheter was inserted for access before surgery and removed upon discharge.
Preinfiltration of Anesthetic Solution
All surgeries were performed in an office setting under local anesthesia with a standardized saline wetting solution consisting of lidocaine, epinephrine, and sodium bicarbonate. Low volumes of buffered 0.5% lidocaine containing 1:200,000 epinephrine (eight parts lidocaine, two parts 8.4% sodium bicarbonate) were injected above the fascial planes to completely anesthetize the sensory nerves. This maneuver was facilitated by grasping the tissues in a fold to separate the skin-fat layers from the underlying muscular-fascial layers. Smaller volumes of 0.5% ropivacaine, up to a maximum of 50 mL, were injected into sensitive areas over bones (costochondral rib margins, iliac crests, paraumbilicus) and along the borders of the anticipated suctioning areas for more prolonged periods of anesthesia.
Phase 1: Infiltration of Tumescent Solutions
The tumescent solution utilized in Phases 1 through 3 contained identical ingredients, with the exception of the milligrams of lidocaine per liter of normal saline (Table 1 ). An infiltration cannula was positioned in the deep subcutaneous fat, after the skin-fat folds were grasped away from the underlying musculofascial structures. The BodyJet system's setting of "1" was selected, which sprayed the prewarmed wetting solution about 2.5 cm in front of the nozzle at the lowest rate, 90 mL per minute. The cannula was moved slowly back and forth in the same tract, yielding a path of hydrodissection as the spray was directed downward on the first pass (toward the fascia) and upward (toward the fat) in a twisting motion during the second pass. Corridors of hydrodissection were generated in a fan-shape pattern, covering the entire zone to be suctioned. The low infiltration rate provided a sufficient level of anesthesia, efficient rinsing of fat lobules, and minimal tissue bogginess in preparation for suctioning.
Phase 2: Simultaneous Irrigation and Aspiration
During Phase 2, a low infiltration setting was preferred over higher settings to allow for more efficient aspiration of minimally turgid tissues. A slow, deliberate "to and fro" motion of the cannula was the most economical maneuver for fatty tissue removal through the predetermined fanshaped pathways once the skin-fat folds were distracted from the underlying muscle fascia. When denser fibrotic tissue was encountered, a cannula was selected that was larger or had a sharper orifice. Also, a higher infiltration rate was found to be possibly more efficient for fat removal, at 750 mm Hg of negative suctioning. The clinical endpoint of fat elimination was determined by a paucity of fatty tissue withdrawn in the tubing, a reduction in the diameter of the grasped fat fold, and the presence of minimal resistance during repetitive passages of the cannula.
Phase 3: Drying
During Phase 3, a cannula with fenestrations on its undersurface was applied to remove remnants of fat beneath the dermis, with a low rate of tumescent solution infiltration and a high level of negative suctioning. During this phase, the cannula was threaded slowly back and forth, with openings directed away from the dermis to minimize skin irregularities. "Feathering" of tissues was performed by deactivating the irrigating and suctioning functions to eliminate any remaining irregularities.
Postoperative Management
A 0.25-inch (0.635-cm) Penrose drain was inserted into one of the dependent openings to facilitate drainage over 24 hours. Other openings were loosely closed with a single suture and dressed with foam sponges. Patients were instructed to wear a compression garment around the area for at least two to three weeks, after which most were able to resume their normal activities. The most common combination was treatment to the hip rolls and abdomen ( Table 2 ). The patients were preoperatively divided into two groups based on the estimated volume of liposuction required (dictated by whether they elected to have multiple-site liposuction during the same procedure).
Results

Beginning in
Group 1
Nineteen patients in the series had smaller volumes of estimated fat to be aspirated. For these patients, the total volume of infiltration solution, total lidocaine dose, and total component volumes of aspiration (infiltration fluid and fat) were recorded from each site after liposuction ( Table 3 ). The average volume of infiltration solution was measured at 2370 mL (range, 450 to 4375 mL), while the average volume of aspiration was calculated to be about 2339 mL (range, 340 to 4150 mL). The average infiltration:aspiration ratio was determined to be 1.1:1.0. The average infiltration:fat ratio was calculated to be 2.8:1.0 (ie, for every 1000 mL of fat removed, 2800 mL of infiltrate was required). The average fat percentage of the total aspirate was 36.5% (range, 14.8% to 73.5%). None of the patients received additional fluid replacement; each patient was hemodynamically stable throughout the entire procedure and in the immediate postoperative recovery period. Lipocrits of less than 1.0% were estimated from millimeters of red blood cells and millimeters of fluid not containing red blood cells, from aspirates measured within centrifuged capillary tubes taken from final aspirates in 15 randomly selected patients.
Group 2
The 22 patients undergoing multiple-site liposuction were estimated to have larger volumes of fat removed and were therefore included in Group 2. The cumulative total volumes of infiltration solution, total lidocaine dose, and total volumes of aspiration (infiltration solution, fat, and blood) were calculated in a similar fashion to the data for Group 1 (Table 4) . In this group, the average volume of tumescent infiltration was 3982 mL (range, 650 to 6000 mL), while the average volume of aspiration was 3502 mL (range, 705 to 6310 mL). The average infiltration:aspiration ratio was calculated to be 1.1:1.0. The average infiltration:fat ratio was determined to be 2.4:1.0 (ie, for every 1000 mL of fat removed, 2400 mL of wetting infiltration was provided). The average fat percentage of the total aspirate was 47.3% (range, 26.8% to 79.5%). Even in these larger procedures, patients were hemodynamically stable throughout the procedures and required no additional fluid resuscitation. Lipocrits of less than 1.0% were estimated with the same method described in Group 1, from final aspirates centrifuged within capillary tubes from 15 randomly selected patients.
Fat Augmentation
Twenty-three patients had fat harvested for augmentation. This portion of the study was performed in nine anatomical sites over 39 procedures (Table 5 ). Abdominal fatty tissue was harvested by repetitive spraying of tumescent solution. Fatty tissue was removed under reduced negative pressure at 450 mm Hg to 500 mm Hg, collected and separated from the infranate at room temperature in the sterile container without washing or centrifugation, and immediately withdrawn under low negative pressures into capped 1-mL or 10-mL injection syringes. Within two hours of harvesting, fat grafting by microdroplet technique was initiated in the majority of patients. Depending on the structural demands of the recipient site, a blunt-tipped micrografting cannula (attached to the filled syringe) was applied to deposit the fat droplets in a fanlike pattern at varying levels in the supraperiosteal, submuscular, and/or subcutaneous planes. Injection occurred during the withdrawal phase so that less pressure was applied, reducing potential damage to the adipocytes. Injection was completed when a satisfactory slight overcorrection was achieved. Further redistribution and smoothing of the infiltrated fat were obtained by rolling the syringe barrel over the grafted site. Selected clinical results between six and eight months postoperatively are shown in Figures 1 to 3 .
Histological Assessment
Fat aliquots from five randomly selected patients were incubated with trypan blue vital dye to determine the percentage of adipocytes that absorbed and expulsed the dye within one hour and six to eight hours after extraction (Figure 4 ). Microscopic assessment after trypan blue dye exclusion test methodology 13 demonstrated that about 90% of adipocytes absorbed and released the dye one hour after aspiration, indicating cell viability. At six to eight hours, less than 10% of examined adipocytes excluded the vital dye, suggesting loss of cell functionality.
Outcomes and Complications
In general, patients reported being satisfied with the changes in their bodies after WAL liposuction at the sixmonth postoperative visit (Figures 5-7) . Each patient was asked to record his or her impression of the degree of intraoperative and postoperative pain on a visual analog scale from 0 to 10. Patient responses indicated an average About 3% of patients developed nodularity within six weeks after surgery. Irregularities were successfully managed by a series of external ultrasound treatments and resolved by three months. There was no incidence of infection, seroma formation, hematoma, blistering, dyschromia, permanent nerve injury, or thrombosis in the lower extremities. In lipoinjected sites, no clinical papules, nodules, or liquefied fat collections were detected. No patient from this series requested revision surgery for insufficient fat removal, asymmetries, or unacceptable irregularities.
disCussion
Liposuction remains one of the most commonly-performed aesthetic surgical procedures 14 and is performed safely and effectively with a number of devices and techniques. Nevertheless, there is debate regarding the clinical merits of delivering controlled thermal injury to collagen fibers by ultrasound, 15 laser, 16 and radiofrequency sources to enhance tissue-tightening results through innovative energized devices versus the well-documented results observed after traditional liposuction.
WAL represents the most recent technical advance, introduced in the United States less than two years ago. The WAL system (in this case, Body-Jet) impacts fatty tissue by directing a spray of tumescent solution to dislodge the fat lobules and "preserve the integrity of blood/lymphatic vessels, nerves, and septae retinaculi cutis." 17, 18 Whenever a new device for liposuction is introduced, there exists not only the necessity for generational improvements, but also advances in treatment algorithms to maximize profiles for safety and efficacy. In addition, the most current device must demonstrate at least equal or superior results to existing successful technologies. 8 While this report does not compare WAL to other (more established) techniques, it does attempt to address specific issues pertinent to the safety and efficacy profiles of this device for small-to-moderate-volume volume liposuction.
To that end, the first parameter for analysis involved the total amount and composition of the infiltration solution instilled into the subcutaneous fat during Phase 1 and in combination with suctioning during Phases 2 and 3, to classify it as a superwet [19] [20] [21] or tumescent 22, 23 technique. One of the distinguishing features that separates these two established techniques is the ratio of total volume of subcutaneous infiltration to final volume of fat aspiration 24 : superwet, 1.0:1.5:1.0; tumescent, 2.0:3.0:1.0. Because of the difficulty in preoperatively identifying the total volume of aspirated fat, clinicians have designated as their final aspiration volume a value that represents the combined volumes of retrieved fat, infiltration fluid, and blood (an infiltrate:aspirate ratio). In this study, the calculated infiltrate:aspirate ratios suggested that the WAL technique could be defined as a superwet procedure (Group 1: 2370 mL infiltration to 2339 mL aspiration = 1.0:1.0; Group 2: 3982 mL infiltration to 3502 mL aspiration = 1.0:1.0). However, according to the infiltrate:fat ratios, WAL could be characterized as a tumescent technique (Group 1: 2370 mL infiltration to 853 mL fat aspiration = 2.8:1.0; Group 2: 3982 mL infiltration to 1656 mL fat aspiration = 2.4:1.0). The relative proportion of these derived ratios for this study's small-to-moderate-volume volume liposuction may not be the same in large-volume liposuction cases with more than 3000 mL of fat removal. Further Seven months after water-assisted liposuction, the patient shows improved sculpting of the back rolls and hips. The total volume of wetting solution infiltrated was about 3500 mL; the total aspiration volume was estimated to be about 2700 mL, of which 1300 mL was fat. The lipocrit was estimated to be about 0.8%. The patient's infiltration and aspiration volumes to her brachii were not included in the data.
experience with a larger number of cases is required to more accurately define safe infiltrate:aspirate volumes, which would limit excessive drug and fluid exposures with this technique.
A second important parameter for analysis was the hemodynamic issue of required fluid resuscitation or blood transfusions when larger volumes of tumescent infiltration and aspiration were encountered during treatment. Preoperatively, patients in this series were instructed to hydrate themselves with six to eight glasses of a balanced electrolyte drink the morning of surgery. Although the total volume of infiltration slightly exceeded the total volume of aspiration, the present study did not focus on the dynamic fluid shifts within the body's compartments as a consequence of surgery. Even so, none of our patients experienced any significant hemodynamic fluid shifts or losses that resulted in detrimental changes to their vital signs (blood pressure, pulse, pulse oximetry, and urine output) during surgery and in the postoperative 24-hour recovery period. Furthermore, none of the patients received parenteral fluid replacement after fat removal of between 150 and 2700 mL. This limited clinical experience suggests enhanced safety in small-to-moderate-volume liposuction cases, but the evidence is not conclusive.
The total amount of blood loss after WAL liposuction was calculated from the estimated lipocrit (expressed as the milliliters of blood present in each milliliter of aspirate, multiplied by the total millimeters of aspirate) and it was found to be negligible in small-and larger-volume cases. Other experienced investigators 19, 22, [25] [26] [27] have reported that superwet or tumescent techniques are accompanied by hemodynamic stability and reduced need for blood transfusions. In spite of the conclusions drawn from these excellent studies, there are still no prospective randomized studies that define the optimal volumes of infiltrate or epinephrine needed to compensate for unsafe fluid shifts, blood losses, and large aspiration volumes. The surgeon should always be prepared to replace volume for patients who require large amounts of fat aspiration (ie, more than 3000 mL), based on clinical judgment and findings.
This study also examined the large amount of lidocaine infused into the subcutaneous tissue with the WAL technique during smaller-volume cases (Group 1 = 10.5 mg/ kg) and larger-volume cases (Group 2 = 20.0 mg/kg). Although the observed lidocaine dosages in these patients were 1.7 to 2.9 times higher than those recommended as safe in the Physicians' Desk Reference 28 (7 mg/kg), they were considerably lower than levels of 30 to 70 mg/kg observed in other reports with tumescent techniques. [29] [30] [31] When plasma lidocaine levels were measured after infiltration of tumescent solution within the subcutaneous tissue in these studies, peak plasma levels of lidocaine occurred at six to 14 hours and were significantly below the safe limit of 5 µ/mL. 25, 29, 31, 32 These studies found that higherthan-recommended dosages of lidocaine appeared to be safe when the drug was placed in the subcutaneous space, which did not facilitate rapid and toxic elevations of serum levels. As previously mentioned, patients in this study did not demonstrate any direct clinical signs or symptoms of lidocaine side effects or toxicity. Nevertheless, when nonrecommended doses of lidocaine are administered, careful monitoring of patients beyond 24 hours will be required, especially in cases with large-volume fat removal and local tumescent anesthesia.
WAL potentially offers a benefit in terms of autologous fat transplantation; as such, that parameter was analyzed in 23 study patients who elected to undergo the additional procedure. Although the fat-harvesting and fat-processing phases of WAL were designed to obtain adipocytes before application, there have been no evidence-based medicine Level 1 or 2 articles 33 (high-quality, multicentered, randomized controlled trials) with this technique for fat harvesting, processing, transfer, and filling. While previous techniques [34] [35] [36] [37] [38] demonstrated no consensus in which fat-grafting methods resulted in definitive evidence of fat survival and retention, WAL shares common elements with the existing options. The observed retention volumes in these study patients during three-to eight-month follow-up represented only an interval estimate based on the author's opinion and not on an Six months after water-assisted liposuction, the patient shows reduction of fat and accommodation of skin to the surgically reduced contour. The total wetting solution infiltrated was 800 mL; the total aspiration volume was recorded at 890 mL, of which 300 mL was fat. The estimated lipocrit was recorded as 0.8%.
evidence-based assessment. Since recent publications [39] [40] [41] [42] reported a resorption rate of 20% to 90% after a year, a larger number of cases-with longer postoperative evaluations (up to two years) and with computed tomography scans or magnetic resonance imaging-may be required to provide an objective and quantitative measurement of graft take.
Despite these lingering questions, patients in this study were satisfied with their outcomes. They experienced minimal postoperative sequelae and were pleased with their postoperative appearance and contour. Since localized heat was not a part of the WAL technique, the degree of skin accommodation suggests other mechanisms for the beneficial skin retraction observed with patients with moderately loose skin. Additional, more sophisticated WAL studies will be required to verify the promising results.
ConClusions
On the basis of limited clinical experience, preliminary data suggest that WAL represents a positive addition to the array of currently available liposuction devices. It offers surgeons the opportunity to impact fatty tissue with a pulsating stream of tumescent solution and simultaneous removal of aspirate under local anesthesia in an officebased procedure. Patients in this series were satisfied with their outcomes, resumed normal activities usually within one to two weeks, and did not request any revision surgeries. The amount of blood loss was negligible, with lipocrits estimated at less than 1.0%. A significant improvement in fat graft survival was not assessed because of the limited number of patients, short follow-up period, and subjective evaluation methods. Further experience will be required to validate these observations.
